Three separate Pharma areas for API and in-house production of KSM with the capacity of 2400 MT per Year. R&D center, well-equipped QC labs.
USFDA/EDQM/UK MHRA/PMDA/Health Canada approvable plant.
Works on Zero effluent discharge.
In-house ETP / MEE and ATFD.
Captive Power Generation – Safe & Uninterrupted operations.
Well-equipped in-house testing Laboratories – Supporting all in-process stages & final products
Well-designed warehouses – Adequate & required storage areas for Engineering, hazardous raw materials and finished Stocks etc.